These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17917258

  • 1. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
    Uchida M, Suzuki M, Shimizu K.
    Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
    [Abstract] [Full Text] [Related]

  • 2. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [Abstract] [Full Text] [Related]

  • 3. R278995/CRA0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication.
    Ahnaou A, Steckler T, Heylen A, Kennis L, Nakazato A, Chaki S, Drinkenburg WH.
    Eur J Pharmacol; 2012 Apr 05; 680(1-3):63-8. PubMed ID: 22314225
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.
    Martínez V, Wang L, Rivier JE, Vale W, Taché Y.
    J Pharmacol Exp Ther; 2002 May 05; 301(2):611-7. PubMed ID: 11961064
    [Abstract] [Full Text] [Related]

  • 7. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
    Perrin MH, Sutton S, Bain DL, Berggren WT, Vale WW.
    Endocrinology; 1998 Feb 05; 139(2):566-70. PubMed ID: 9449626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Corticotropin releasing factor (CRF) modulates fear-induced alterations in sleep in mice.
    Yang L, Tang X, Wellman LL, Liu X, Sanford LD.
    Brain Res; 2009 Jun 18; 1276():112-22. PubMed ID: 19376095
    [Abstract] [Full Text] [Related]

  • 10. Impact of state of arousal and stress neuropeptides on urodynamic function in freely moving rats.
    Kiddoo DA, Valentino RJ, Zderic S, Ganesh A, Leiser SC, Hale L, Grigoriadis DE.
    Am J Physiol Regul Integr Comp Physiol; 2006 Jun 18; 290(6):R1697-706. PubMed ID: 16439667
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y, Dong L, Yin D.
    J Gastroenterol Hepatol; 2008 Jul 18; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
    Xu Y, Zhang R, Chen J, Zhang Q, Wang J, Hu J, Guan X, Jin L, Fu H, Gui B, Guo Y, Li S.
    Br J Pharmacol; 2009 Aug 18; 157(8):1368-79. PubMed ID: 19572944
    [Abstract] [Full Text] [Related]

  • 17. Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors.
    Robbins MT, Ness TJ.
    J Pain; 2008 Nov 18; 9(11):991-8. PubMed ID: 18632307
    [Abstract] [Full Text] [Related]

  • 18. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice.
    Moffatt JD, Lever R, Page CP.
    FASEB J; 2006 Sep 18; 20(11):1877-9. PubMed ID: 16855006
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
    Pelleymounter MA, Joppa M, Ling N, Foster AC.
    J Pharmacol Exp Ther; 2002 Jul 18; 302(1):145-52. PubMed ID: 12065711
    [Abstract] [Full Text] [Related]

  • 20. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
    Million M, Maillot C, Saunders P, Rivier J, Vale W, Taché Y.
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan 18; 282(1):G34-40. PubMed ID: 11751155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.